GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (LTS:0A4M) » Definitions » Short-Term Debt

DexCom (LTS:0A4M) Short-Term Debt : $0 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is DexCom Short-Term Debt?

DexCom's Short-Term Debt for the quarter that ended in Sep. 2024 was $0 Mil.

DexCom's annual Short-Term Debt increased from Dec. 2021 ($0 Mil) to Dec. 2022 ($773 Mil) but then declined from Dec. 2022 ($773 Mil) to Dec. 2023 ($0 Mil).


DexCom Short-Term Debt Historical Data

The historical data trend for DexCom's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Short-Term Debt Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 772.60 -

DexCom Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.20 - - - -

DexCom Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


DexCom Short-Term Debt Related Terms

Thank you for viewing the detailed overview of DexCom's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom Headlines

No Headlines